Cargando…
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy
SIMPLE SUMMARY: Cancer is still the leading cause of disease-related death in pediatric populations and an important source of morbidity. These can be due to the neoplasm itself but also to the treatment administered; infants are patients of special vulnerability. The aim of this work was to identif...
Autores principales: | Urtasun, Andrea, Olivera, Gladys G., Sendra, Luis, Aliño, Salvador F., Berlanga, Pablo, Gargallo, Pablo, Hervás, David, Balaguer, Julia, Juan-Ribelles, Antonio, Andrés, María del Mar, Cañete, Adela, Herrero, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000841/ https://www.ncbi.nlm.nih.gov/pubmed/36900216 http://dx.doi.org/10.3390/cancers15051424 |
Ejemplares similares
-
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
por: Olivera, Gladys, et al.
Publicado: (2019) -
Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
por: Olivera, Gladys G., et al.
Publicado: (2021) -
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
por: Olivera, Gladys G., et al.
Publicado: (2020) -
Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells
por: Fernández-Delgado, Manuel, et al.
Publicado: (2022) -
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
por: Juan Ribelles, Antonio, et al.
Publicado: (2021)